United States-based pharmaceutical company Amgen (NASDAQ: AMGN) announced on Wednesday that it has named Michael V Drake, MD, as its new director, effective immediately.
In addition to the newly appointed role, Dr Drake will also serve as a member of the board's Corporate Responsibility and Compliance Committee and its Governance and Nominating Committee.
Dr Drake currently serves as the president of the University of California. He has earlier held the position of president of the Ohio State University (OSU). He has also worked as chancellor of the University of California, Irvine and has also served as UC Irvine's systemwide vice president for health affairs.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer